|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1401 to 1500 out of 2260 for Erbb2

<< First    < Previous  |  Next >    Last >>
0.019s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
15253274 | J:91417
First Author: Kosanke S
Year: 2004
Journal: Comp Med
Title: Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.
Volume: 54
Issue: 3
Pages: 280-7
•
•
•
•
•
Publication
21932419 | J:186138
First Author: Margalit O
Year: 2012
Journal: Int J Cancer
Title: Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function.
Volume: 131
Issue: 4
Pages: E562-8
•
•
•
•
•
Publication
19017793 | J:142214
First Author: Xue Y
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome.
Volume: 105
Issue: 47
Pages: 18513-8
•
•
•
•
•
Publication
19276366 | J:147366
First Author: Santisteban M
Year: 2009
Journal: Cancer Res
Title: Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Volume: 69
Issue: 7
Pages: 2887-95
•
•
•
•
•
Publication
20841468 | J:164678
First Author: Cheng X
Year: 2010
Journal: Cancer Res
Title: Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.
Volume: 70
Issue: 19
Pages: 7684-9
•
•
•
•
•
Publication
23430951 | J:198306
First Author: Pierpaoli E
Year: 2013
Journal: Carcinogenesis
Title: Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
Volume: 34
Issue: 6
Pages: 1352-60
•
•
•
•
•
Publication
18421311 | J:153418
First Author: Sas S
Year: 2008
Journal: Cancer Gene Ther
Title: Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
Volume: 15
Issue: 10
Pages: 655-66
•
•
•
•
•
Publication
31355130 | J:281857
 
First Author: Dodda BR
Year: 2019
Journal: Front Oncol
Title: Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
Volume: 9
Pages: 525
•
•
•
•
•
Publication
22038845 | J:186122
First Author: Dong LF
Year: 2012
Journal: Int J Cancer
Title: α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability.
Volume: 131
Issue: 5
Pages: 1052-8
•
•
•
•
•
Publication
19148488 | J:156981
First Author: Jacquemart IC
Year: 2009
Journal: Int J Oncol
Title: Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Volume: 34
Issue: 2
Pages: 517-28
•
•
•
•
•
Publication
17970045 | J:133602
First Author: Freitas I
Year: 2007
Journal: Anticancer Res
Title: Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement.
Volume: 27
Issue: 5A
Pages: 3059-65
•
•
•
•
•
Publication
23269276 | J:194361
First Author: Ladd JJ
Year: 2013
Journal: Cancer Res
Title: Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.
Volume: 73
Issue: 5
Pages: 1502-13
•
•
•
•
•
Publication
21346233 | J:170836
First Author: Uram JN
Year: 2011
Journal: J Immunol
Title: Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.
Volume: 186
Issue: 7
Pages: 3847-57
•
•
•
•
•
Publication
19480910 | J:151437
First Author: Turánek J
Year: 2009
Journal: Toxicol Appl Pharmacol
Title: Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice.
Volume: 237
Issue: 3
Pages: 249-57
•
•
•
•
•
Publication
12734063 | J:84226
First Author: Pape-Ansorge KA
Year: 2002
Journal: Nutr Cancer
Title: Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice.
Volume: 44
Issue: 2
Pages: 162-8
•
•
•
•
•
Publication
22846914 | J:191321
First Author: Patel RA
Year: 2012
Journal: Cancer Res
Title: RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
Volume: 72
Issue: 19
Pages: 5025-34
•
•
•
•
•
Publication
39191486 | J:353832
 
First Author: Fernando V
Year: 2024
Journal: Life Sci Alliance
Title: Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.
Volume: 7
Issue: 11
•
•
•
•
•
Publication
16393983 | J:126446
First Author: Murata S
Year: 2006
Journal: J Immunol
Title: OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
Volume: 176
Issue: 2
Pages: 974-83
•
•
•
•
•
Publication
10925363 | J:64150
First Author: Kurt RA
Year: 2000
Journal: Int J Cancer
Title: Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.
Volume: 87
Issue: 5
Pages: 688-94
•
•
•
•
•
Publication
26383165 | J:226777
First Author: Jain S
Year: 2015
Journal: Cancer Res
Title: Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.
Volume: 75
Issue: 22
Pages: 4863-75
•
•
•
•
•
Publication
21779410 | J:174933
First Author: Persson J
Year: 2011
Journal: PLoS One
Title: Immuno-therapy with anti-CTLA4 antibodies in tolerized and non-tolerized mouse tumor models.
Volume: 6
Issue: 7
Pages: e22303
•
•
•
•
•
Publication
31772036 | J:285660
First Author: Karimian A
Year: 2020
Journal: Cancer Res
Title: Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy.
Volume: 80
Issue: 4
Pages: 868-876
•
•
•
•
•
Publication
29326437 | J:261031
First Author: Ikink GJ
Year: 2018
Journal: Oncogene
Title: Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
Volume: 37
Issue: 12
Pages: 1594-1609
•
•
•
•
•
Publication
29985529 | J:269003
First Author: Payne KK
Year: 2018
Journal: J Leukoc Biol
Title: Gr1-/low CD11b-/low MHCII+ myeloid cells boost T cell anti-tumor efficacy.
Volume: 104
Issue: 6
Pages: 1215-1228
•
•
•
•
•
Publication
24769444 | J:212553
First Author: Qin L
Year: 2014
Journal: Cancer Res
Title: NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Volume: 74
Issue: 13
Pages: 3477-88
•
•
•
•
•
Publication
24778415 | J:212552
First Author: Cecil DL
Year: 2014
Journal: Cancer Res
Title: Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.
Volume: 74
Issue: 10
Pages: 2710-8
•
•
•
•
•
Publication
29113931 | J:257790
 
First Author: Winocur G
Year: 2018
Journal: Neuroscience
Title: Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
Volume: 369
Pages: 51-65
•
•
•
•
•
Publication
28819024 | J:245658
First Author: Gall VA
Year: 2017
Journal: Cancer Res
Title: Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
Volume: 77
Issue: 19
Pages: 5374-5383
•
•
•
•
•
Publication
10919650 | J:63663
First Author: Sfondrini L
Year: 2000
Journal: Cancer Res
Title: Cooperative effects of Mycobacterium tuberculosis Ag38 gene transduction and interleukin 12 in vaccination against spontaneous tumor development in proto-neu transgenic mice.
Volume: 60
Issue: 14
Pages: 3777-81
•
•
•
•
•
Publication
28536279 | J:245579
First Author: McFarland CD
Year: 2017
Journal: Cancer Res
Title: The Damaging Effect of Passenger Mutations on Cancer Progression.
Volume: 77
Issue: 18
Pages: 4763-4772
•
•
•
•
•
Publication
24435044 | J:207979
First Author: Zhou B
Year: 2014
Journal: J Clin Invest
Title: Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.
Volume: 124
Issue: 2
Pages: 553-63
•
•
•
•
•
Publication
16423990 | J:106497
First Author: Murata S
Year: 2006
Journal: Cancer Res
Title: Ductal access for prevention and therapy of mammary tumors.
Volume: 66
Issue: 2
Pages: 638-45
•
•
•
•
•
Publication
18794141 | J:141309
First Author: Sharma S
Year: 2008
Journal: Cancer Res
Title: Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.
Volume: 68
Issue: 18
Pages: 7530-40
•
•
•
•
•
Publication
19934325 | J:155535
First Author: Warin R
Year: 2009
Journal: Cancer Res
Title: Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.
Volume: 69
Issue: 24
Pages: 9473-80
•
•
•
•
•
Publication
11402305 | J:80581
First Author: Pupa SM
Year: 2001
Journal: Gene Ther
Title: Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
Volume: 8
Issue: 1
Pages: 75-9
•
•
•
•
•
Publication
18794138 | J:141310
First Author: Whittington PJ
Year: 2008
Journal: Cancer Res
Title: DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies.
Volume: 68
Issue: 18
Pages: 7502-11
•
•
•
•
•
Publication
16778222 | J:110102
First Author: Carothers AM
Year: 2006
Journal: Cancer Res
Title: Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.
Volume: 66
Issue: 12
Pages: 6432-8
•
•
•
•
•
Publication
19920193 | J:155052
First Author: Song H
Year: 2009
Journal: Cancer Res
Title: Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Volume: 69
Issue: 23
Pages: 8941-8
•
•
•
•
•
Publication
16740714 | J:110109
First Author: Kaminski R
Year: 2006
Journal: Cancer Res
Title: Role of SRC kinases in Neu-induced tumorigenesis: challenging the paradigm using Csk homologous kinase transgenic mice.
Volume: 66
Issue: 11
Pages: 5757-62
•
•
•
•
•
Publication
15489885 | J:95289
First Author: Alli PM
Year: 2005
Journal: Oncogene
Title: Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Volume: 24
Issue: 1
Pages: 39-46
•
•
•
•
•
Publication
28228558 | J:252371
First Author: Markiewski MM
Year: 2017
Journal: J Immunol
Title: The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.
Volume: 198
Issue: 7
Pages: 2989-2999
•
•
•
•
•
Publication
29040431 | J:257857
First Author: Pore SK
Year: 2018
Journal: Carcinogenesis
Title: Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.
Volume: 39
Issue: 2
Pages: 134-145
•
•
•
•
•
Publication
12224018 | J:79069
First Author: Sacco MG
Year: 2002
Journal: Gene Ther
Title: Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice.
Volume: 9
Issue: 19
Pages: 1338-41
•
•
•
•
•
Publication
20826047 | J:165813
First Author: Stannard KA
Year: 2010
Journal: Cancer Lett
Title: Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.
Volume: 299
Issue: 2
Pages: 95-110
•
•
•
•
•
Publication
18278493 | J:139821
First Author: Kmieciak M
Year: 2008
Journal: Cancer Immunol Immunother
Title: Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design.
Volume: 57
Issue: 9
Pages: 1391-8
•
•
•
•
•
Publication
17579068 | J:125804
First Author: Allen SD
Year: 2007
Journal: J Immunol
Title: Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo.
Volume: 179
Issue: 1
Pages: 472-82
•
•
•
•
•
Publication
23722543 | J:199474
First Author: Le Mercier I
Year: 2013
Journal: Cancer Res
Title: Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.
Volume: 73
Issue: 15
Pages: 4629-40
•
•
•
•
•
Publication
16013040 | J:101390
First Author: Acevedo R
Year: 2005
Journal: J Appl Toxicol
Title: The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency.
Volume: 25
Issue: 5
Pages: 339-53
•
•
•
•
•
Publication
9714068 | J:52636
First Author: Lollini PL
Year: 1998
Journal: Int J Cancer
Title: Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.
Volume: 77
Issue: 6
Pages: 937-41
•
•
•
•
•
Publication
22039576 | J:185635
First Author: DeNardo DG
Year: 2011
Journal: Cancer Discov
Title: Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
Volume: 1
Issue: 1
Pages: 54-67
•
•
•
•
•
Publication
25043044 | J:217110
First Author: Tseng YY
Year: 2014
Journal: Nature
Title: PVT1 dependence in cancer with MYC copy-number increase.
Volume: 512
Issue: 7512
Pages: 82-6
•
•
•
•
•
Publication
15705886 | J:96381
First Author: Liu B
Year: 2005
Journal: Cancer Res
Title: Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
Volume: 65
Issue: 3
Pages: 879-86
•
•
•
•
•
Publication
23821767 | J:199457
First Author: Hahm ER
Year: 2013
Journal: J Natl Cancer Inst
Title: Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.
Volume: 105
Issue: 15
Pages: 1111-22
•
•
•
•
•
Publication
20363920 | J:160749
First Author: Anisimov VN
Year: 2010
Journal: Am J Pathol
Title: Rapamycin extends maximal lifespan in cancer-prone mice.
Volume: 176
Issue: 5
Pages: 2092-7
•
•
•
•
•
Publication
15690207 | J:97899
First Author: Astolfi A
Year: 2005
Journal: Cancer Immunol Immunother
Title: Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
Volume: 54
Issue: 6
Pages: 599-610
•
•
•
•
•
Publication
14693742 | J:87505
First Author: Lanza-Jacoby S
Year: 2003
Journal: Cancer Epidemiol Biomarkers Prev
Title: The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
Volume: 12
Issue: 12
Pages: 1486-91
•
•
•
•
•
Publication
24909172 | J:221264
First Author: Robichaux JP
Year: 2015
Journal: Oncogene
Title: Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.
Volume: 34
Issue: 15
Pages: 2003-10
•
•
•
•
•
Publication
14679152 | J:87515
First Author: Lu C
Year: 2003
Journal: J Natl Cancer Inst
Title: Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
Volume: 95
Issue: 24
Pages: 1825-33
•
•
•
•
•
Publication
24632612 | J:219258
First Author: Kumagai Y
Year: 2015
Journal: Oncogene
Title: Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu mice.
Volume: 34
Issue: 8
Pages: 1051-7
•
•
•
•
•
Publication
14632631 | J:87020
First Author: Simpson PT
Year: 2003
Journal: Int J Exp Pathol
Title: Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.
Volume: 84
Issue: 4
Pages: 173-84
•
•
•
•
•
Publication
16597642 | J:113345
First Author: Malewicz B
Year: 2006
Journal: Carcinogenesis
Title: Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements.
Volume: 27
Issue: 9
Pages: 1739-47
•
•
•
•
•
Publication
15623464 | J:96292
First Author: Cleary MP
Year: 2004
Journal: Nutr Cancer
Title: Diet-induced obesity and mammary tumor development in MMTV-neu female mice.
Volume: 50
Issue: 2
Pages: 174-80
•
•
•
•
•
Publication
12359744 | J:79691
First Author: Howe LR
Year: 2002
Journal: Cancer Res
Title: Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
Volume: 62
Issue: 19
Pages: 5405-7
•
•
•
•
•
Publication
25342465 | J:258637
First Author: Ju JH
Year: 2015
Journal: Cell Death Differ
Title: Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes.
Volume: 22
Issue: 4
Pages: 665-76
•
•
•
•
•
Publication
14666678 | J:87525
First Author: Freitas I
Year: 2003
Journal: Anticancer Res
Title: Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice.
Volume: 23
Issue: 5A
Pages: 3783-94
•
•
•
•
•
Publication
14530326 | J:85932
First Author: Manjili MH
Year: 2003
Journal: J Immunol
Title: HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
Volume: 171
Issue: 8
Pages: 4054-61
•
•
•
•
•
Publication
28040797 | J:245794
 
First Author: Samanta SK
Year: 2017
Journal: J Natl Cancer Inst
Title: Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
Volume: 109
Issue: 6
•
•
•
•
•
Publication
16724093 | J:115815
First Author: Chan T
Year: 2006
Journal: Gene Ther
Title: HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
Volume: 13
Issue: 19
Pages: 1391-402
•
•
•
•
•
Publication
10203064 | J:54329
First Author: Esserman LJ
Year: 1999
Journal: Cancer Immunol Immunother
Title: Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice.
Volume: 47
Issue: 6
Pages: 337-42
•
•
•
•
•
Publication
21555371 | J:173621
First Author: Asiedu MK
Year: 2011
Journal: Cancer Res
Title: TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.
Volume: 71
Issue: 13
Pages: 4707-19
•
•
•
•
•
Publication
16488990 | J:106663
First Author: Kwak EL
Year: 2006
Journal: Cancer Res
Title: Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.
Volume: 66
Issue: 4
Pages: 1923-8
•
•
•
•
•
Publication
19356843 | J:150689
First Author: Kalliomäki TM
Year: 2009
Journal: Cancer Lett
Title: Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia.
Volume: 282
Issue: 1
Pages: 98-108
•
•
•
•
•
Publication
34997154 | J:317488
First Author: Reich LA
Year: 2022
Journal: Sci Rep
Title: The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer.
Volume: 12
Issue: 1
Pages: 293
•
•
•
•
•
Publication
28474672 | J:249568
 
First Author: Morris EJ
Year: 2017
Journal: Nat Commun
Title: Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1.
Volume: 8
Pages: 15289
•
•
•
•
•
Publication
28581518 | J:248101
First Author: Sengupta S
Year: 2017
Journal: Oncogene
Title: Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
Volume: 36
Issue: 41
Pages: 5709-5721
•
•
•
•
•
Publication
30478213 | J:270060
First Author: Segatto I
Year: 2019
Journal: Cancer Res
Title: Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis.
Volume: 79
Issue: 2
Pages: 397-409
•
•
•
•
•
Strain
MGI:5538672 | FVB/N-Tg(MMTV-Erbb2)NK1Mul
Attribute String: coisogenic, mutant strain, transgenic
•
•
•
•
•
Strain
MGI:3038209 | FVB-Tg(MMTV-Erbb2)NK1Mul/J
Attribute String: mutant strain, transgenic, coisogenic
•
•
•
•
•
Publication
17947490 | J:131196
First Author: Li Y
Year: 2007
Journal: Clin Cancer Res
Title: The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Volume: 13
Issue: 20
Pages: 6224-31
•
•
•
•
•
Publication
21743488 | J:181067
First Author: Pradeep CR
Year: 2012
Journal: Oncogene
Title: Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.
Volume: 31
Issue: 7
Pages: 907-17
•
•
•
•
•
Publication
28404630 | J:242909
First Author: Rodriguez-Barrueco R
Year: 2017
Journal: Genes Dev
Title: miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.
Volume: 31
Issue: 6
Pages: 553-566
•
•
•
•
•
Publication
19173004 | J:144833
First Author: Cameron HL
Year: 2009
Journal: PLoS One
Title: Developmental and lactational exposure to dieldrin alters mammary tumorigenesis in Her2/neu transgenic mice.
Volume: 4
Issue: 1
Pages: e4303
•
•
•
•
•
Publication
33382695 | J:300159
First Author: Sharma M
Year: 2020
Journal: PLoS One
Title: Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice.
Volume: 15
Issue: 12
Pages: e0234893
•
•
•
•
•
Publication
15572297 | J:95478
First Author: Luijten M
Year: 2004
Journal: Nutr Cancer
Title: Effects of soy-derived isoflavones and a high-fat diet on spontaneous mammary tumor development in Tg.NK (MMTV/c-neu) mice.
Volume: 50
Issue: 1
Pages: 46-54
•
•
•
•
•
Publication
16201849 | J:104183
First Author: Thomsen AR
Year: 2005
Journal: Nutr Cancer
Title: Influence of Prevastein, an isoflavone-rich soy product, on mammary gland development and tumorigenesis in Tg.NK (MMTV/c-neu) mice.
Volume: 52
Issue: 2
Pages: 176-88
•
•
•
•
•
Publication
22302033 | J:184943
First Author: Roberts PJ
Year: 2012
Journal: J Natl Cancer Inst
Title: Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
Volume: 104
Issue: 6
Pages: 476-87
•
•
•
•
•
Publication
- | J:92112
First Author: Mortensen A
Year: 2004
Journal: Asia Pac J Clin Nutr
Title: Investigation of the effect of lignans on murine mammary gland differentiation in TG.NK mice.
Volume: 13
Issue: Suppl
Pages: S172
•
•
•
•
•
Publication
18362934 | J:137272
First Author: Li Y
Year: 2008
Journal: Br J Cancer
Title: The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Volume: 98
Issue: 8
Pages: 1380-8
•
•
•
•
•
Publication
23975425 | J:212608
First Author: Qian X
Year: 2014
Journal: Oncogene
Title: N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
Volume: 33
Issue: 26
Pages: 3411-21
•
•
•
•
•
Publication
28596550 | J:287493
First Author: Provinciali M
Year: 2017
Journal: Sci Rep
Title: Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span.
Volume: 7
Issue: 1
Pages: 3078
•
•
•
•
•
Publication
16424043 | J:106547
First Author: Law M
Year: 2006
Journal: Cancer Res
Title: Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
Volume: 66
Issue: 2
Pages: 1070-80
•
•
•
•
•
Publication
25855725 | J:222566
First Author: Pérez-Gómez E
Year: 2015
Journal: J Natl Cancer Inst
Title: Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.
Volume: 107
Issue: 6
Pages: djv077
•
•
•
•
•
Publication
34305544 | J:314230
 
First Author: Berry A
Year: 2021
Journal: Front Behav Neurosci
Title: Chronic Isolation Stress Affects Central Neuroendocrine Signaling Leading to a Metabolically Active Microenvironment in a Mouse Model of Breast Cancer.
Volume: 15
Pages: 660738
•
•
•
•
•
Publication
33947955 | J:306068
First Author: Arora I
Year: 2021
Journal: Sci Rep
Title: Systematic integrated analyses of methylomic and transcriptomic impacts of early combined botanicals on estrogen receptor-negative mammary cancer.
Volume: 11
Issue: 1
Pages: 9481
•
•
•
•
•
Publication
17229545 | J:121510
First Author: Luijten M
Year: 2007
Journal: Reprod Toxicol
Title: Modulation of mammary tumor development in Tg.NK (MMTV/c-neu) mice by dietary fatty acids and life stage-specific exposure to phytoestrogens.
Volume: 23
Issue: 3
Pages: 407-13
•
•
•
•
•
Publication
9342440 | J:43631
First Author: Rao GN
Year: 1997
Journal: Breast Cancer Res Treat
Title: Influence of diet on mammary cancer in transgenic mice bearing an oncogene expressed in mammary tissue.
Volume: 45
Issue: 2
Pages: 149-58
•
•
•
•
•
Allele
Tg(MMTV-Erbb2*)NDL1-2Mul | MGI:3793944
Name: transgene insertion NDL1-2, William J Muller
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
•
•
•
•
•
Allele
Tg(MMTV-Erbb2*)NDL1-4Mul | MGI:3793947
Name: transgene insertion NDL1-4, William J Muller
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
•
•
•
•
•
Allele
Tg(MMTV-Erbb2*)NDL2-1Mul | MGI:3793948
Name: transgene insertion NDL2-1, William J Muller
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
•
•
•
•
•
Allele
Tg(MMTV-Erbb2*)NDL2-5Mul | MGI:3793949
Name: transgene insertion NDL2-5, William J Muller
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom